Besides, among four kinds of IGF2 promoters, IGF2-P3 and IGF2-P4 have a high expression in bladder tumor tissues compared with normal bladder, which confirming their values in target therapy (44, 45). The gene discussed is IGF2; the disease is urinary bladder neoplasm.